Technical Analysis for ALT - Altimmune, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Evening Star | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | -10.00% | |
| Spinning Top | Other | -10.00% | |
| Upper Bollinger Band Walk | Strength | -10.00% |
| Alert | Time |
|---|---|
| Down 10% | 3 days ago |
| Down 1 ATR | 3 days ago |
| 60 Minute Opening Range Breakdown | 3 days ago |
| Fell Below 50 DMA | 3 days ago |
| 50 DMA Support | 3 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/09/2024
Altimmune, Inc. Description
Altimmune,Inc., formerly Pharmathene, Inc., is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Phosphates Manufacturing Process Obesity Vaccines Reversal Manufacturing Processes Nerve Biodefense Choline Biological Warfare Anthrax Chemical Warfare Cholinesterase Anthrax Vaccines Athene
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.84 |
| 52 Week Low | 2.09 |
| Average Volume | 3,646,906 |
| 200-Day Moving Average | 6.33 |
| 50-Day Moving Average | 8.33 |
| 20-Day Moving Average | 7.44 |
| 10-Day Moving Average | 7.77 |
| Average True Range | 0.72 |
| RSI (14) | 51.69 |
| ADX | 15.58 |
| +DI | 30.54 |
| -DI | 21.72 |
| Chandelier Exit (Long, 3 ATRs) | 7.33 |
| Chandelier Exit (Short, 3 ATRs) | 8.46 |
| Upper Bollinger Bands | 8.64 |
| Lower Bollinger Band | 6.24 |
| Percent B (%b) | 0.74 |
| BandWidth | 32.33 |
| MACD Line | 0.02 |
| MACD Signal Line | -0.21 |
| MACD Histogram | 0.2323 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.43 | ||||
| Resistance 3 (R3) | 9.54 | 9.17 | 9.19 | ||
| Resistance 2 (R2) | 9.17 | 8.81 | 9.12 | 9.11 | |
| Resistance 1 (R1) | 8.59 | 8.59 | 8.41 | 8.48 | 9.03 |
| Pivot Point | 8.23 | 8.23 | 8.13 | 8.17 | 8.23 |
| Support 1 (S1) | 7.65 | 7.86 | 7.46 | 7.54 | 6.99 |
| Support 2 (S2) | 7.28 | 7.64 | 7.23 | 6.91 | |
| Support 3 (S3) | 6.70 | 7.28 | 6.83 | ||
| Support 4 (S4) | 6.59 |
